Earnings Feed
Start Free
Home/Filings/4/A/0001209191-09-046439
4/A//SEC Filing

Egan James 4/A

Accession 0001209191-09-046439

CIK 0001365216other
View on SEC.govCompany Profile

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 5:11 PM ET

Size

6.1 KB

Accession

0001209191-09-046439

Insider Transaction Report

Form 4/AAmended
Period: 2009-09-23
Sucampo Pharmaceuticals, Inc.SCMP
Egan James
Chief Operating Officer
Transactions
  • Award

    Employee Stock Option (Right to buy)

    2009-09-23+60,000→ 60,000 total
    Exercise: $5.87Exp: 2019-09-23→ Class A common stock (60,000 underlying)
Footnotes (2)
  • [F1]This report is being filed to amend the incorrect vesting start dates.
  • [F2]With regard to 30,000 shares of Class A common stock underlying the option, vesting commences on September 23, 2012 in four equal annual installments and with regard to the balance of 30,000 shares of Class A common stock underlying the option, vesting commences on September 23, 2013 in four equal annual installments.

Documents

1 file

Issuer

Sucampo Pharmaceuticals, Inc.

CIK 0001365216

→
Entity typeother

Related Parties

1
  • filerCIK 0001296997

Filing Metadata

Form type
4/A
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 5:11 PM ET
Size
6.1 KB
View on SEC.gov